anmelden
BX Swiss TOP 30 CHF
1.513,33
PKT
+2,95
PKT
+0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.03.12 | Swiss Life buy | Sarasin Research | |
| 05.03.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 01.03.12 | Sika neutral | Sarasin Research | |
| 01.03.12 | Lindt neutral | Sarasin Research | |
| 01.03.12 | Adecco SA buy | Sarasin Research | |
| 01.03.12 | Holcim neutral | Credit Suisse Group | |
| 01.03.12 | Adecco SA buy | ING | |
| 01.03.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
| 29.02.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 29.02.12 | Swiss Life buy | Sarasin Research | |
| 29.02.12 | Sonova neutral | Sarasin Research | |
| 29.02.12 | Holcim neutral | Sarasin Research | |
| 28.02.12 | Nestlé overweight | Morgan Stanley | |
| 28.02.12 | Swiss Re equal-weight | Morgan Stanley | |
| 27.02.12 | Swiss Re underperform | RBC Capital Markets | |
| 24.02.12 | Swiss Re kaufen | Hamburger Sparkasse AG (Haspa) | |
| 24.02.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 24.02.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 24.02.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 24.02.12 | Zurich Insurance outperform | Macquarie Research | |
| 24.02.12 | Swiss Re neutral | Nomura | |
| 24.02.12 | Swiss Re underperform | RBC Capital Markets | |
| 24.02.12 | Swiss Life buy | Nomura | |
| 24.02.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.02.12 | Roche overweight | J.P. Morgan Cazenove | |
| 23.02.12 | Swiss Re buy | Sarasin Research | |
| 22.02.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 22.02.12 | Straumann neutral | Sarasin Research | |
| 22.02.12 | Zurich Insurance hold | Commerzbank Corp. & Markets | |
| 22.02.12 | Holcim hold | Deutsche Bank AG | |
| 21.02.12 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 21.02.12 | Schindler buy | Sarasin Research | |
| 21.02.12 | Givaudan neutral | Credit Suisse Group | |
| 21.02.12 | ABB (Asea Brown Boveri) outperform | Cheuvreux SA | |
| 21.02.12 | Swisscom buy | Nomura | |
| 21.02.12 | Julius Bär buy | Sarasin Research | |
| 21.02.12 | Zurich Insurance outperform | RBC Capital Markets | |
| 21.02.12 | Zurich Insurance halten | Independent Research GmbH | |
| 20.02.12 | Holcim neutral | Citigroup Corp. | |
| 20.02.12 | Zurich Insurance buy | ING |
